Trial
NCT01788280
Preliminary Assessment of [18F] Fluciclatide (GE [18F]AH111585) in Glioblastoma Multiforme Treated With Bevacizumab
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Utah
Collaborators
—
Condition
Glioblastoma Multiforme (GBM)
Intervention
Fluciclitite , PET imaging, and Bevacizumab
Why stopped
Unable to get materials from GE, study not proceeding and never opened to accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-02-07